NCT01253447 2018-08-27AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 2 Completed19 enrolled 8 charts
NCT01231919 2014-04-29MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaNational Cancer Institute (NCI)Phase 1 Completed45 enrolled